Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. (Q50906224)
Jump to navigation
Jump to search
scientific article published on 13 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. |
scientific article published on 13 June 2013 |
Statements
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. (English)
1 reference
1 reference
1 reference
Arthur Kavanaugh
1 reference
Alice B Gottlieb
1 reference
Proton Rahman
1 reference
Christopher Ritchlin
1 reference
Carrie Brodmerkel
1 reference
Shu Li
1 reference
Yuhua Wang
1 reference
Alan M Mendelsohn
1 reference
Mittie K Doyle
1 reference
PSUMMIT 1 Study Group
1 reference
13 June 2013
1 reference
382
1 reference
9894
1 reference
780-789
1 reference